Genesco Inc. (GCO)
NYSE: GCO
· Real-Time Price · USD
21.26
-0.47 (-2.16%)
At close: Jun 02, 2025, 2:47 PM
Genesco Revenue Breakdown
| Period Ending | Feb 1, 2025 | Feb 3, 2024 | Jan 28, 2023 | Jan 29, 2022 | Jan 30, 2021 | Feb 1, 2020 | Feb 2, 2019 | Feb 3, 2018 | Jan 28, 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Johnston And Murphy Group Segment Revenue | 320.21M | 339.46M | 314.76M | 252.85M | 152.94M | 1.46B | 1.42B | 2.66B | 2.5B |
| Johnston And Murphy Group Segment Revenue Growth | -5.67% | +7.85% | +24.48% | +65.33% | -89.53% | +2.84% | -46.60% | +6.22% | n/a |
| Journeys Group Segment Revenue | 1.4B | 1.36B | 1.48B | 1.58B | 1.23B | 373.93M | 382.59M | 807.4M | 745.74M |
| Journeys Group Segment Revenue Growth | +2.57% | -7.99% | -5.98% | +28.38% | +228.39% | -2.26% | -52.61% | +8.27% | n/a |
| Schuh Group Segment Revenue | 479.89M | 480.16M | 432M | 423.56M | 305.94M | n/a | n/a | n/a | n/a |
| Schuh Group Segment Revenue Growth | -0.06% | +11.15% | +1.99% | +38.44% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Feb 1, 2025 | Nov 2, 2024 | Aug 3, 2024 | May 4, 2024 | Feb 3, 2024 | Oct 28, 2023 | Jul 29, 2023 | Apr 29, 2023 | Jan 28, 2023 | Oct 29, 2022 | Jul 30, 2022 | Apr 30, 2022 | Jan 29, 2022 | Oct 30, 2021 | Jul 31, 2021 | May 1, 2021 | Jan 30, 2021 | Oct 31, 2020 | Aug 1, 2020 | May 2, 2020 | Feb 1, 2020 | Nov 2, 2019 | Aug 3, 2019 | May 4, 2019 | Feb 2, 2019 | Nov 3, 2018 | Aug 4, 2018 | May 5, 2018 | Feb 3, 2018 | Oct 28, 2017 | Jul 29, 2017 | Apr 29, 2017 | Jan 28, 2017 | Oct 29, 2016 | Jul 30, 2016 | Apr 30, 2016 | Jan 30, 2016 | Oct 31, 2015 | Aug 1, 2015 | May 2, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 301.86M | 274.91M | 255.13M | 247.83M | 303.55M | 267.47M | 259.52M | 251.5M | 285.78M | 267.73M | 245.1M | 243.48M | 290.48M | 251.13M | 252.55M | 239.47M | 226.51M | 210.96M | 187.26M | 189.04M | 260.61M | 237.46M | 231.8M | 236.56M | 262.88M | 327.1M | 319.04M | 322.12M | 374.12M | 322.74M | 308.46M | 316M | 350.76M | 314.7M | 302.66M | 308.24M | 348.78M | 321.69M | 306.42M | 307.43M | 336.39M |
| Selling, General, and Administrative Revenue Growth | +9.80% | +7.75% | +2.95% | -18.36% | +13.49% | +3.06% | +3.19% | -12.00% | +6.74% | +9.23% | +0.67% | -16.18% | +15.67% | -0.56% | +5.46% | +5.72% | +7.37% | +12.66% | -0.94% | -27.46% | +9.75% | +2.44% | -2.01% | -10.01% | -19.63% | +2.53% | -0.96% | -13.90% | +15.92% | +4.63% | -2.39% | -9.91% | +11.46% | +3.98% | -1.81% | -11.62% | +8.42% | +4.98% | -0.33% | -8.61% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |